ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1990

Effects of Exercise on Movement-Evoked Pain in People with Knee Osteoarthritis

Ehyun Kim1, Tuhina Neogi2, Benjamin Senderling1, Mary Gheller1, Lee Marinko1, Michael LaValley3, Lukas Adamowicz4, Pirinka Georgiev4, Charmaine Demanuele4, Paul Wacnik4 and Deepak Kumar1, 1Boston University, Boston, MA, 2Boston University School of Medicine, Boston, MA, 3Boston University School of Public Health, Arlington, MA, 4Pfizer Inc., Cambridge, MA

Meeting: ACR Convergence 2023

Keywords: exercise, Osteoarthritis, pain, physical therapy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Movement-evoked pain (MEP), i.e., pain that appears with or is made worse by movement, is a common complaint in people with knee osteoarthritis (OA). MEP is more intense and bothersome than spontaneous pain and is related to greater disability. However, little is known about whether exercise, the first-line recommendation for managing chronic pain due to knee OA, can reduce MEP and factors that may predict treatment response. The objectives of this study were: (1) to investigate the effect of a 12-week exercise-based physical therapy intervention on MEP in people with knee OA and (2) to examine whether baseline psychological factors and nociceptive dysfunction predict change in MEP.

Methods: For this study, we used data from a single-arm clinical trial (#NCT04243096) of a 12-week exercise intervention in people with symptomatic knee OA (n = 60, Table 1) with age ≥ 50 and BMI ≤ 40 kg/m2. Participants received 18 sessions (8 via telehealth) of an exercise intervention with a physical therapist over 12 weeks. Our primary outcome was MEP during functional activities (functional MEP), and secondary outcomes included exercise MEP and knee pain during nominated activity (PainNA, 0-10 scale) (Figure 1). These outcomes were assessed at baseline, and weeks 6, 12, and 18. At baseline, nociceptive functioning was assessed using quantitative sensory testing that included pressure pain threshold (PPT), mechanical temporal summation (TS), and conditioned pain modulation (CPM). At baseline, participants also completed Center for Epidemiologic Studies Depression Scale (CES-D), Central Sensitization Inventory (CSI), and pain catastrophizing scale (PCS; 3-items). Responders were individuals with ≥ 50% improvement in functional MEP from baseline to week 12. The effect of an exercise intervention on MEP from baseline to follow-up was evaluated with mixed model repeated measures (MMRM) adjusting for age, sex, BMI, and presence of comorbidities. Log-binomial regression was used to determine whether any baseline measures predicted treatment response based on functional MEP while adjusting for sex and BMI.

Results: We observed a significant improvement in all MEP outcomes with exercise at week 6 and week 12 with the improvements being sustained at week 18 (Figure 2). In our cohort, 63.2% of participants met our definition of responders based on functional MEP. None of the baseline measures were predictive of treatment response based on functional MEP.

Conclusion: Participants with symptomatic knee OA undergoing a 12-week exercise intervention demonstrated reductions in MEP, supporting the use of exercise as a core treatment for this population. Given the lack of a control group, it is possible that regression to the mean or other factors may have contributed to observed improvements in MEP. While minimal important change for functional MEP and exercise MEP is not known, the improvements in PainNA at week 12 were clinically meaningful. The lack of associations between baseline psychological factors as well as measures of nociceptive function suggests that exercise may be an effective intervention for MEP, irrespective of alterations in these measures in people with knee OA.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: E. Kim: None; T. Neogi: None; B. Senderling: None; M. Gheller: None; L. Marinko: None; M. LaValley: None; L. Adamowicz: Pfizer, 3; P. Georgiev: Pfizer, 3, 11; C. Demanuele: Pfizer, 3, 11; P. Wacnik: Pfizer, 11; D. Kumar: Eli Lilly, 5, Pfizer, 5.

To cite this abstract in AMA style:

Kim E, Neogi T, Senderling B, Gheller M, Marinko L, LaValley M, Adamowicz L, Georgiev P, Demanuele C, Wacnik P, Kumar D. Effects of Exercise on Movement-Evoked Pain in People with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/effects-of-exercise-on-movement-evoked-pain-in-people-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-exercise-on-movement-evoked-pain-in-people-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology